Skip to content

iktos vs Terray Therapeutics

iktos logo

iktos

Artificial intelligence for new drug design

62 employees · est. 2016 · Paris, France

VS
Terray Therapeutics logo

Terray Therapeutics

Everything small molecule drug discovery should be

142 employees · est. 2018 · Pasadena, United States

iktos is the older company (2016 vs 2018).

Side-by-Side Comparison

iktos Terray Therapeutics
Founded
2016 older 2018
Headquarters
Paris, France Pasadena, United States
Employees
62 142
Industry
AI, Biotechnology, Health Care AI, Biopharma, Biotechnology
Funding Stage
Series A Series B
Total Funding
$18.90M $195.00M
Funding Rounds
7 5
Services
Generative AI Platform (Makya), AI-Driven Retrosynthesis (Spaya), Automated Drug Development Pipeline, Autonomous Lab Robotics AI and experimental hardware development for drug discovery, Creating custom datasets for pharmaceutical research, Drug design and development for small molecules
Target Customers
Pharmaceutical Companies, Biotech Firms, Academic Institutions, Medicinal and Computational Chemists, Drug Discovery Teams Biotechnology companies, Pharmaceutical firms, Research institutions, Healthcare organizations
Taxonomy
Drug DesignMedicinal ChemistryGenerative AIChemoinformaticsRobotics AutomationSaaS Software +8 Small Molecule Drug DiscoveryUltra-high Throughput ExperimentationGenerative AIMedicinal ChemistryNanotechnologyData-driven Drug Development +7
Website
iktos.ai terraytx.com
iktos logo

About iktos

Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," encapsulates its mission to leverage cutting-edge technologies for medicinal chemistry. The company's...

Terray Therapeutics logo

About Terray Therapeutics

Terray Therapeutics, founded in 2018, is an innovative biotechnology company dedicated to transforming small molecule drug discovery. Their slogan, "Everything small molecule drug discovery should be.", encapsulates their commitment to revolutionizing this space. The company leverages a powerful pl...

Also comparing in this category

Comparing more than these two?

Get iktos, Terray Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does iktos compare?

A PDF of iktos and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

iktos was founded in 2016, based in Paris, France, with 62 employees. Iktos, founded in 2016 and headquartered in France, stands out as a leader in the convergence of AI and biotechnology for drug discovery. Its slogan, "Artificial intelligence for new drug design," enc. Terray Therapeutics was founded in 2018, based in Pasadena, United States, with 142 employees. Terray Therapeutics, founded in 2018, is an innovative biotechnology company dedicated to transforming small molecule drug discovery. Their slogan, "Everything small molecule drug discovery should be.
iktos has raised $18.90M and Terray Therapeutics $195.00M. Latest stage: iktos Series A, Terray Therapeutics Series B.
Both work in AI and Biotechnology and list medicinal chemistry and generative ai among their focus areas.

Compare iktos with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at iktos on 20 Sep 2026, and Terray Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout